Properties of specific binding site of myotoxin a, a powerful convulsant, in brain microsomes

Canadian Journal of Physiology and Pharmacology

Volumn 76, Issue 4, 1998, Pages 395-400

  Katagiri, Chikako ^a   Ishikawa, Hiro Hide ^a   Ohkura, Masamichi ^a   Nakagawasai, Osam ^b   Tadano, Takeshi ^b   Kisara, Kensuke ^b   Ohizumi, Yasushi ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Brain microsomes; Central nervous system; Myotoxin a; Powerful convulsion; Specific binding site

Indexed keywords

MYOTOXIN A; SNAKE VENOM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRAIN MICROSOME; CONVULSION; MALE; MUSCLE NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SARCOPLASMIC RETICULUM; TOXICITY TESTING;

ANIMALS; BRAIN; CROTALID VENOMS; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICROSOMES; RATS; RATS, WISTAR;

EID: 0031697379     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/cjpp-76-4-395     Document Type: Article

References (14)

1. 2+ releaser. J. Pharm. Pharmacol. 46: 774-776.
2. Baker, B., Tu, A.T., and Middlebrook, J.L. 1993. Binding of myotoxin a to cultured muscle cells. Toxicon, 31: 271-284.
3. Brittain, R.T., and Handley, S.L. 1967. Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J. Physiol. (London), 192: 805-813.
4. Cameron, D.L., and Tu, AT. 1977. Characterization of myotoxin a from the venom of prairie rattlesnake (Crotalus viridis viridis). Biochemistry, 224: 89-96.
5. 2+ release properties in sarcoplasmic reticulum. Br. J. Pharmacol. 113: 233-239.
6. 2+ release channel. J. Biol. Chem. 268: 13 765-13 768.
7. Meldrum, B. 1988. What are the future prospects for agents decreasing excitatory neurotransmitter as anti-epileptic agent? In Frontiers in excitatory amino acid research. Edited by E.A. Cavalheiro, J. Lehmann, and L. Turski. Alan R. Liss Inc., New York. p. 195.
8. Ohizumi, Y. 1997. Application of physiologically active substances isolated from natural resources to pharmacological studies. Jpn. J. Pharmacol. 73: 263-289.
9. ++ releasing agent, in skeletal muscle sarcoplasmic reticulum. J. Pharmacol. Exp. Ther. 273: 934-939.
10. 2+ release induced by myotoxin a in skeletal muscle sarcoplasmic reticulum. Can. J. Physiol. Pharmacol. 73: 1181-1185.
11. Sillen, L.G., and Martell, A.E. 1964. Stability constants of metal-ion complexes. The Chemical Society, London.
12. Sillen, L.G., and Martell, A.E. 1971. Stability constants of metal-ion complexes. Suppl. 1. The Chemical Society, London.
13. 2+-ATPase of skeletal muscle sarcoplasmic reticulum. Arch. Biochem. Biophys. 246: 90-97.
14. Yudkowsky, M.L., Beech, J., and Fletcher, J.E. 1994. Myotoxin a reduces the threshold for calcium-induced calcium release in skeletal muscle. Toxicon. 32: 273-278.